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Background
Nonsteroidal antiinflammatory drugs (NSAIDs) and
antibiotics are widely used drugs and are the leading
causes of adverse drug reaction (ADR), especially skin
reactions. The photosensitizing effects of piroxicam are
known for a long time and triggered by a photoproduct
structurally similar to antigenic thiosalicylic acid present
in the chemical formula of thimerosal and piroxicam.
The thimerosal is a preservative used in topical products
such as: antiseptics, eye drops, solutions for contact lens
and vaccines. Patients sensitized to thimerosal may have
photosensitivity reactions with the use of piroxicam by
cross reaction to thiosalicylic acid.
Methods
Literature review and case description.
Results
Female patient, 37 years, from São Paulo came to our
clinic for evaluation due to lombocitalgy therapy caused
by a disc herniation. She reported a history of flushing,
reddish plaques and itching in the body 24 hours after
using diclofenac and piroxicam simultaneouly. At the
Emergency Department received promethazine, methyl-
prednisolone and dexchlorpheniramine and the lesions
subsided in few hours. Another episode occurred after a
hysterectomy surgery, when she received tenoxicam,
dipyrone, metoclopramide and cefazolin. Next day, there
were “urticaria” plaques in cervical and abdominal region.
The patient was treated with antihistamine and improve-
ment after 1 week. We performed a Patch Test with pirox-
icam, tenoxicam and thimerosal in the concentration of
10%. The first reading was done in 48 hours and evidenced
erythema and bullous lesions for thimerosal and erythema
for piroxican. The 96 hours reading showed microvesicles,
erythema and pseudopods for piroxicam and erythema
and microvesicles for thimerosal. The patch test was nega-
tive with tenoxicam.
Conclusions
Piroxicam may induce photoallergy through a photopro-
duct, wich is structurally similar to the antigenic thiosa-
licylic acid present in the formula of thimerosal. There is
no evidence of cross-reaction between piroxicam and
tenoxicam, because this photoproduct is not formed upon
irradiation of tenoxicam. The diagnosis of drug photosen-
sitivity reaction is performed by clinical history associated
with photo patch test.
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